[{"address1": "9000 Virginia Manor Road", "address2": "Suite 200", "city": "Beltsville", "state": "MD", "zip": "20705", "country": "United States", "phone": "240 399 4900", "website": "https://www.nextcure.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "NextCure, Inc., a clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer. The company's product candidate is the LNCB74, a B7-H4 targeted ADC to kill tumors. It also develops NC410, a fusion protein of LAIR-2, that is designed to block immune suppression mediated by LAIR-1; NC525, a novel LAIR-1 antibody that targets acute myeloid leukemia, blast cells, and leukemic stem cells; NC181 a humanized antibody targeting ApoE4 for the treatment of Alzheimer's disease; and NC605 an antibody that targets Siglec-15, as well as chronic bone diseases, such as osteoarthritis and non-union fractures. The company also develop SIM0505, a novel antibody-drug conjugate (ADC) targeting CDH6 (cadherin-6 or K-cadherin) for the treatment of solid tumors. NextCure, Inc. was incorporated in 2015 and is headquartered in Beltsville, Maryland.", "fullTimeEmployees": 43, "companyOfficers": [{"maxAge": 1, "name": "Mr. Michael S. Richman MSBA", "age": 63, "title": "Co-Founder, CEO, President & Director", "yearBorn": 1961, "fiscalYear": 2024, "totalPay": 852699, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Timothy  Mayer Ph.D.", "age": 59, "title": "Chief Operating Officer", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 619306, "exercisedValue": 0, "unexercisedValue": 12677}, {"maxAge": 1, "name": "Dr. Lieping  Chen M.D., Ph.D.", "age": 67, "title": "Co-Founder & Chairman of Scientific Advisory Board", "yearBorn": 1957, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Steven P. Cobourn CPA", "age": 60, "title": "Chief Financial Officer", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 313251, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kevin G. Shaw", "age": 49, "title": "Senior VP & General Counsel", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Sourav  Kundu Ph.D.", "age": 63, "title": "Senior Vice President of Development & Manufacturing", "yearBorn": 1961, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Sebastien  Maloveste Ph.D.", "title": "Senior Vice President of Business Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Udayan  Guha M.D., Ph.D.", "age": 52, "title": "Chief Medical Officer", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 7, "compensationRisk": 8, "shareHolderRightsRisk": 6, "overallRisk": 7, "governanceEpochDate": 1761955200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 9.82, "open": 9.97, "dayLow": 8.96, "dayHigh": 10.56, "regularMarketPreviousClose": 9.82, "regularMarketOpen": 9.97, "regularMarketDayLow": 8.96, "regularMarketDayHigh": 10.56, "payoutRatio": 0.0, "beta": 1.558, "forwardPE": -6.2657347, "volume": 21219, "regularMarketVolume": 21219, "averageVolume": 37082, "averageVolume10days": 53550, "averageDailyVolume10Day": 53550, "bid": 7.36, "ask": 11.69, "bidSize": 2, "askSize": 2, "marketCap": 23977946, "fiftyTwoWeekLow": 2.688, "fiftyTwoWeekHigh": 19.2, "allTimeHigh": 1308.0, "allTimeLow": 2.688, "fiftyDayAverage": 7.30348, "twoHundredDayAverage": 6.527265, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -3438599, "profitMargins": 0.0, "floatShares": 1704976, "sharesOutstanding": 2676110, "sharesShort": 10909, "sharesShortPriorMonth": 31406, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.0041, "heldPercentInsiders": 0.14793, "heldPercentInstitutions": 0.39248002, "shortRatio": 0.88, "shortPercentOfFloat": 0.0041, "impliedSharesOutstanding": 2676110, "bookValue": 28.053, "priceToBook": 0.31939542, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -60927000, "trailingEps": -25.97, "forwardEps": -1.43, "lastSplitFactor": "1:12", "lastSplitDate": 1752451200, "enterpriseToEbitda": 0.056, "52WeekChange": -0.45098037, "SandP52WeekChange": 0.12121439, "quoteType": "EQUITY", "currentPrice": 8.96, "targetHighPrice": 20.0, "targetLowPrice": 15.0, "targetMeanPrice": 17.5, "targetMedianPrice": 17.5, "recommendationMean": 2.33333, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "totalCash": 35308000, "totalCashPerShare": 13.194, "ebitda": -61203000, "totalDebt": 5590000, "quickRatio": 3.294, "currentRatio": 3.712, "debtToEquity": 18.856, "returnOnAssets": -0.53122, "returnOnEquity": -1.0588, "freeCashflow": -33357000, "operatingCashflow": -54130000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "NXTC", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "shortName": "NextCure, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1557408600000, "postMarketChangePercent": 0.44642815, "postMarketPrice": 9.0, "postMarketChange": 0.03999996, "regularMarketChange": -0.86, "regularMarketDayRange": "8.96 - 10.56", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 37082, "fiftyTwoWeekLowChange": 6.2720003, "fiftyTwoWeekLowChangePercent": 2.3333335, "fiftyTwoWeekRange": "2.688 - 19.2", "fiftyTwoWeekHighChange": -10.240001, "fiftyTwoWeekHighChangePercent": -0.53333336, "fiftyTwoWeekChangePercent": -45.098038, "earningsTimestampStart": 1753873140, "earningsTimestampEnd": 1754308800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -25.97, "epsForward": -1.43, "epsCurrentYear": -22.84, "priceEpsCurrentYear": -0.39229423, "fiftyDayAverageChange": 1.6565199, "fiftyDayAverageChangePercent": 0.2268124, "twoHundredDayAverageChange": 2.432735, "twoHundredDayAverageChangePercent": 0.37270355, "corporateActions": [], "postMarketTime": 1762553552, "regularMarketTime": 1762549200, "exchange": "NMS", "messageBoardId": "finmb_321460821", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -8.75763, "regularMarketPrice": 8.96, "longName": "NextCure, Inc.", "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.3 - Buy", "cryptoTradeable": false, "displayName": "NextCure", "trailingPegRatio": null, "__fetch_time": "2025-11-08"}]